Journal article
Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial
Abstract
BACKGROUND: Influenza increases the risk of cardiovascular events and deaths. We aimed to see whether influenza vaccination reduces death and vascular events in patients with heart failure.
METHODS: We did a pragmatic, randomised, double-blind, placebo-controlled trial in 30 centres (mostly hospitals affliated with universities or a research institute) in ten countries in Asia, the Middle East, and Africa (7 in India, 4 in Philippines, 4 in …
Authors
Loeb M; Roy A; Dokainish H; Dans A; Palileo-Villanueva LM; Karaye K; Zhu J; Liang Y; Goma F; Damasceno A
Journal
The Lancet Global Health, Vol. 10, No. 12, pp. e1835–e1844
Publisher
Elsevier
Publication Date
12 2022
DOI
10.1016/s2214-109x(22)00432-6
ISSN
2572-116X